Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-25 @ 7:38 PM
Study NCT ID:
NCT00281632
Status:
COMPLETED
Last Update Posted:
2018-09-17
First Post:
2006-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-23
First Submit QC Date:
None
Study First Post Date:
2006-01-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-11-25
Results First Submit QC Date:
None
Results First Post Date:
2011-01-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-13
Last Update Post Date:
2018-09-17
Last Update Post Date Type:
ACTUAL